StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

TFA Therapeutics's shares outstanding was 111M at Dec 31, 2023. For fiscal 2025 it was 111M, up 0.0% from the year before. The highest annual figure on record is 111M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025111M0.0%
FY2024Dec 31, 2024111M0.0%
FY2023Dec 31, 2023111M+6.4%
FY2022Dec 31, 2022104M+104317.5%
FY2021Dec 31, 20210M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023111M–
Q4 FY2022Dec 31, 2022118M–

More TFA Therapeutics figures

See a number that looks wrong?